New Delhi: The expert panel of Drug Controller General of India (DCGI) on Thursday recommended that emergency use authorization be granted to the COVID-19 vaccine Corbevax for children in the age group of 5 to 12 years.
Corbevax, developed by Hyderabad-based firm Biological-E, is India’s first indigenously-developed RBD protein sub-unit vaccine against the coronavirus.
It is being administered to children in the age group of 12 to 14 from March 16, 2022.
Meanwhile, the government panel has sought more data from Bharat Biotech before granting emergency use approval to Covaxin among children aged 5-12.
The 5-12 age group is yet to brought under the nationwide inoculation drive.
Bhubaneswar: The Odisha government is set to engage ‘bank mitras’ to resolve problems faced by…
New Delhi: The Supreme Court on Monday (Nov 25) dismissed petitions challenging the inclusion of…
Bhubaneswar: The State Transport Authority (STA) of Odisha has seized the scooter of jatra actress…
Bareilly: Blind trust on technology can be detrimental too. That’s exactly what happened to three…
New Delhi: Proceedings in both Lok Sabha and Rajya Sabha for the ongoing Winter Session…
Cuttack: After rescuing a minor Bangladeshi girl, Madhupatna Police in Odisha’s Cuttack city have arrested…
Baripada: Ten days after being put in a soft enclosure inside Similipal Tiger Reserve (STR)…
Nuapada: Inspector In-Charge (IIC) of Jonk police station in Odisha’s Nuapada district, Gurudev Karmi, has…